Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia
DA Shah, RA Khalil - Biochemical pharmacology, 2015 - Elsevier
Preeclampsia is a pregnancy-associated disorder characterized by hypertension, and could
lead to maternal and fetal morbidity and mortality; however, the pathophysiological …
lead to maternal and fetal morbidity and mortality; however, the pathophysiological …
Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small‐for‐gestational‐age infants
AEP Heazell, DJL Hayes, M Whitworth… - Cochrane Database …, 2019 - cochranelibrary.com
Background Stillbirth affects 2.6 million pregnancies worldwide each year. Whilst the
majority of cases occur in low‐and middle‐income countries, stillbirth remains an important …
majority of cases occur in low‐and middle‐income countries, stillbirth remains an important …
Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions …
Background Placental lesions consistent with maternal vascular underperfusion (MVU) are
thought to be pathogenically linked to preeclampsia, small-for-gestational-age newborns …
thought to be pathogenically linked to preeclampsia, small-for-gestational-age newborns …
Circulating biomarkers associated with placental dysfunction and their utility for predicting fetal growth restriction
J Hong, S Kumar - Clinical Science, 2023 - portlandpress.com
Fetal growth restriction (FGR) leading to low birth weight (LBW) is a major cause of neonatal
morbidity and mortality worldwide. Normal placental development involves a series of highly …
morbidity and mortality worldwide. Normal placental development involves a series of highly …
The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia
Abstract Objective: To determine (1) whether maternal plasma concentrations of angiogenic
and anti-angiogenic factors can predict which mothers diagnosed with “suspected small for …
and anti-angiogenic factors can predict which mothers diagnosed with “suspected small for …
Systematic review of maternal Placental Growth Factor levels in late pregnancy as a predictor of adverse intrapartum and perinatal outcomes
Aim This systematic review evaluates the utility of maternal Placental Growth Factor (PlGF)
when measured in late pregnancy (> 20 weeks) as a predictor of adverse obstetric and …
when measured in late pregnancy (> 20 weeks) as a predictor of adverse obstetric and …
Prediction of small‐for‐gestational‐age neonates: screening by biophysical and biochemical markers at 30–34 weeks
S Bakalis, G Peeva, R Gonzalez… - … in Obstetrics & …, 2015 - Wiley Online Library
Objective To investigate the potential value of combined screening by maternal
characteristics and medical history (maternal factors), estimated fetal weight (EFW), uterine …
characteristics and medical history (maternal factors), estimated fetal weight (EFW), uterine …
[HTML][HTML] Prediction of preeclampsia and intrauterine growth restriction: development of machine learning models on a prospective cohort
H Sufriyana, YW Wu, ECY Su - JMIR medical informatics, 2020 - medinform.jmir.org
Background: Preeclampsia and intrauterine growth restriction are placental dysfunction–
related disorders (PDDs) that require a referral decision be made within a certain time …
related disorders (PDDs) that require a referral decision be made within a certain time …
Longitudinal changes in maternal serum placental growth factor and soluble fms‐like tyrosine kinase‐1 in women at increased risk of pre‐eclampsia
Objectives To investigate longitudinal changes in maternal serum levels of placental growth
factor (PlGF) and soluble fms‐like tyrosine kinase‐1 (sFlt‐1) in pregnant women who …
factor (PlGF) and soluble fms‐like tyrosine kinase‐1 (sFlt‐1) in pregnant women who …
Serum biomarkers combined with uterine artery Doppler in prediction of preeclampsia
L Li, Y Zheng, Y Zhu, J Li - … and therapeutic medicine, 2016 - spandidos-publications.com
First-trimester screening may be a major advantage over a second-trimester approach since
it opens prospects for early and more efficient interventions. The aim of the current study was …
it opens prospects for early and more efficient interventions. The aim of the current study was …